Blocking the Aryl Hydrocarbon Receptor Alleviates Myocardial Ischemia/Reperfusion Injury in Rats

Abstract

Objective

Restoring the blood perfusion of ischemic heart tissues is the main treatment for myocardial ischemia. However, the accompanying myocardial ischemia reperfusion injury (IRI) would aggravate myocardial damage. Previous studies have confirmed that aryl hydrocarbon receptor (AhR) is closely correlated to kidney and intestinal IRI. The present study aimed to explore the relationship between AhR and myocardial IRI.

Methods

An oxygen glucose deprivation/reoxygenation (OGD/R) model of H9c2 cells and an ischemia/reperfusion (I/R) model of Sprague-Dawley rat myocardium were established. OGD/R cells and myocardial IRI rats were treated with different concentrations of the AhR antagonist CH-223191 or agonist 6-formylindolo[3,2-b] carbazole (FICZ). Under the conditions of normoxia and hypoxia/reoxygenation, the activity of cardiomyocytes, lactate dehydrogenase (LDH) and cell reactive oxygen species (ROS) were detected. In rats, myocardial pathological damage and markers of myocardial injury were detected.

Results

According to the results of the cell viability, LDH and ROS tests in vitro, both CH-223191 and FICZ showed no myocardial protection under OGD/R conditions. However, the histological staining and analysis of myocardial injury marker LDH in vitro revealed that CH-223191 could significantly reduce the myocardial IRI.

Conclusion

AhR exhibited a different effect on myocardial IRI in vitro and in vivo. In vivo, CH-223191 could significantly alleviate the myocardial IRI, suggesting that inhibition of AhR may play a role in myocardial protection, and AhR may serve as a potential treatment target for myocardial IRI.

Keywords

aryl hydrocarbon receptor / ischemia/reperfusion injury / myocardial protection / CH-223191 / 6-formylindolo[3,2-b]carbazole

References

[1] DreyerRP, SciriaC, SpatzES, et al.. Young Women With Acute Myocardial Infarction: Current Perspectives. Circ Cardiovasc Qual Outcomes, 2017, 10(2): e003480

[2] PiperHM, AbdallahY, SchäferC. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res, 2004, 61(3): 365-371

[3] ZhouH, ToanS, ZhuP, et al.. DNA-PKcs promotes cardiac ischemia reperfusion injury through mitigating BI-1-governed mitochondrial homeostasis. Basic Res Cardiol, 2020, 115(2): 11

[4] KanzawaN, KondoM, OkushimaT, et al.. Biochemical and molecular biological analysis of different responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin in chick embryo heart and liver. Arch Biochem Biophys, 2004, 427(1): 58-67

[5] StevensEA, MezrichJD, BradfieldCA. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology, 2009, 127(3): 299-311

[6] WuH, LiuB, YangK, et al.. Synthesis and biological evaluation of FICZ analogues as agonists of aryl hydrocarbon receptor. Bioorg Med Chem Lett, 2020, 30(5): 126959

[7] MehrabiMR, SteinerGE, DellingerC, et al.. The arylhydrocarbon receptor (AhR), but not the AhR-nuclear translocator (ARNT), is increased in hearts of patients with cardiomyopathy. Virchows Arch, 2002, 441(5): 481-489

[8] ZhangY, WangY, MaZ, et al.. Ginsenoside Rb1 Inhibits Doxorubicin-Triggered H9C2 Cell Apoptosis via Aryl Hydrocarbon Receptor. Biomol Ther (Seoul), 2017, 25(2): 202-212

[9] XueY, ShuiX, SuW, et al.. Baicalin inhibits inflammation and attenuates myocardial ischaemic injury by aryl hydrocarbon receptor. J Pharm Pharmacol, 2015, 67(12): 1756-1764

[10] ThackaberryEA, GabaldonDM, WalkerMK, et al.. Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxia-inducible factor-1alpha in the absence of cardiac hypoxia. Cardiovasc Toxicol, 2002, 2(4): 263-274

[11] VasquezA, Atallah-YunesN, SmithFC, et al.. A role for the aryl hydrocarbon receptor in cardiac physiology and function as demonstrated by AhR knockout mice. Cardiovasc Toxicol, 2003, 3(2): 153-163

[12] VilahurG, CubedoJ, CasaniL, et al.. Reperfusion-triggered stress protein response in the myocardium is blocked by post-conditioning. Systems biology pathway analysis highlights the key role of the canonical aryl-hydrocarbon receptor pathway. Eur Heart J, 2013, 34(27): 2082-2093

[13] Silva-PalaciosA, Ostolga-ChavarríaM, Sánchez-GaribayC, et al.. Sulforaphane protects from myocardial ischemia-reperfusion damage through the balanced activation of Nrf2/AhR. Free Radic Biol Med, 2019, 143: 331-340

[14] GaoJ, SunZ, XiaoZ, et al.. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury. Br J Anaesth, 2019, 123(6): 827-838

[15] NebertDW, RoeAL, DieterMZ, et al.. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol, 2000, 59(1): 65-85

[16] KimE, KimHC, LeeS, et al.. Dexmedetomidine confers neuroprotection against transient global cerebral ischemia/reperfusion injury in rats by inhibiting inflammation through inactivation of the TLR-4/NF-κB pathway. Neurosci Lett, 2017, 649: 20-27

[17] HaniehH. Toward understanding the role of aryl hydrocarbon receptor in the immune system: current progress and future trends. Biomed Res Int, 2014, 2014: 520763

[18] ChenO, YeZ, CaoZ, et al.. Methane attenuates myocardial ischemia injury in rats through anti-oxidative, anti-apoptotic and anti-inflammatory actions. Free Radic Biol Med, 2016, 90: 1-11

[19] PiperHM, García-DoradoD, OvizeM. A fresh look at reperfusion injury. Cardiovasc Res, 1998, 38(2): 291-300

[20] WangJ, ToanS, ZhouH. New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis, 2020, 23(3): 299-314

[21] WangJ, ZhouH. Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia-reperfusion injury. Acta Pharm Sin B, 2020, 10(10): 1866-1879

[22] TanY, MuiD, ToanS, et al.. SERCA Overexpression Improves Mitochondrial Quality Control and Attenuates Cardiac Microvascular Ischemia-Reperfusion Injury. Mol Ther Nucleic Acids, 2020, 22: 696-707

[23] KimSH, HenryEC, KimDK, et al.. Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3, 7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol, 2006, 69(6): 1871-1878

[24] BabanB, LiuJY, MozaffariMS. Aryl hydrocarbon receptor agonist, leflunomide, protects the ischemic-reperfused kidney: role of Tregs and stem cells. Am J Physiol Regul Integr Comp Physiol, 2012, 303(11): R1136-1146

[25] VrbaJ, KrenV, VacekJ, et al.. Quercetin, quercetin glycosides and taxifolin differ in their ability to induce AhR activation and CYP1A1 expression in HepG2 cells. Phytother Res, 2012, 26(11): 1746-1752

[26] WangY, ZhangZZ, WuY, et al.. Quercetin postconditioning attenuates myocardial ischemia/reperfusion injury in rats through the PI3K/Akt pathway. Braz J Med Biol Res, 2013, 46(10): 861-867

[27] KorashyHM, El-KadiAO. The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases. Drug Metab Rev, 2006, 38(3): 411-450

[28] ZhangS, QinC, SafeSH. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ Health Perspect, 2003, 111(16): 1877-1882

[29] FurueM, UchiH, MitomaC, et al.. Implications of tryptophan photoproduct FICZ in oxidative stress and terminal differentiation of keratinocytes. G Ital Dermatol Venereol, 2019, 154(1): 37-41

[30] ZhangZ, PuA, YuM, et al.. Aryl hydrocarbon receptor activation modulates γδ intestinal intraepithelial lymphocytes and protects against ischemia/reperfusion injury in the murine small intestine. Mol Med Rep, 2019, 19(3): 1840-1848

[31] GhormadePS, KumarNB, TingneCV, et al.. Distribution & diagnostic efficacy of cardiac markers CK-MB & LDH in pericardial fluid for postmortem diagnosis of ischemic heart disease. J Forensic Leg Med, 2014, 28: 42-46

[32] QuD, HanJ, RenH, et al.. Cardioprotective Effects of Astragalin against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart. Oxid Med Cell Longev, 2016, 2016: 8194690

[33] OzerMK, ParlakpinarH, CigremisY, et al.. Ischemia-reperfusion leads to depletion of glutathione content and augmentation of malondialdehyde production in the rat heart from overproduction of oxidants: can caffeic acid phenethyl ester (CAPE) protect the heart?. Mol Cell Biochem, 2005, 273(1–2): 169-175

[34] HolmströmKM, FinkelT. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol, 2014, 15(6): 411-421

[35] LiuZ, LiL, ChenW, et al.. Aryl hydrocarbon receptor activation maintained the intestinal epithelial barrier function through Notch1 dependent signaling pathway. Int J Mol Med, 2018, 41(3): 1560-1572

[36] ZhuH, TanY, DuW, et al.. Phosphoglycerate mutase 5 exacerbates cardiac ischemia-reperfusion injury through disrupting mitochondrial quality control. Redox Biol, 2021, 38: 101777